Robert A Soslow Selected Research

Mucinous Adenocarcinoma (Mucinous Carcinoma)

1/2019	Cervical adenosquamous carcinoma: detailed analysis of morphology, immunohistochemical profile, and clinical outcomes in 59 cases.
1/2018	International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.
5/2016	Low-Stage High-Grade Serous Ovarian Carcinomas: Support for an Extraovarian Origin.
5/2008	Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
1/2005	Expression of cancer-testis antigens in endometrial carcinomas using a tissue microarray.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert A Soslow Research Topics

Disease

86	Neoplasms (Cancer) 10/2022 - 05/2002
44	Endometrial Neoplasms (Endometrial Cancer) 10/2022 - 10/2002
42	Carcinoma (Carcinomatosis) 01/2022 - 10/2002
19	Endometrioid Carcinoma 03/2022 - 10/2002
16	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 09/2003
13	Adenocarcinoma 01/2022 - 10/2002
8	Leiomyosarcoma 01/2019 - 09/2004
6	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 04/2013
6	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2020 - 11/2009
5	Carcinosarcoma 01/2022 - 05/2013
5	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2019 - 01/2005
5	Carcinogenesis 04/2013 - 10/2002
5	Wilms Tumor (Wilm's Tumor) 01/2011 - 02/2008
4	Endometrial Stromal Sarcoma 01/2022 - 01/2005
4	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2006
4	Microsatellite Instability 01/2020 - 10/2012
4	Neoplasm Metastasis (Metastasis) 01/2017 - 08/2008
4	Uterine Neoplasms (Uterine Cancer) 01/2017 - 05/2006
3	Disease Progression 01/2021 - 09/2012
3	Leiomyoma (Uterine Fibroids) 10/2017 - 08/2011
3	Renal Cell Carcinoma (Grawitz Tumor) 10/2017 - 08/2011
2	Hyperplasia 03/2022 - 03/2010
2	Adenosarcoma 01/2020 - 04/2013
2	Necrosis 01/2020 - 05/2013
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 03/2004
2	Ovarian Epithelial Carcinoma 01/2018 - 10/2006
2	Leiomyomatosis 10/2017 - 07/2014
2	Small Cell Carcinoma 01/2016 - 09/2003
2	Colorectal Neoplasms (Colorectal Cancer) 12/2014 - 11/2009
2	Smooth Muscle Tumor 07/2014 - 04/2006
2	Carcinoma in Situ 12/2012 - 09/2008
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2006 - 05/2003
1	Perivascular Epithelioid Cell Neoplasms 01/2022
1	Lymphatic Metastasis 01/2021

Drug/Important Bio-Agent (IBA)

30	Proteins (Proteins, Gene)FDA Link 10/2022 - 08/2003
14	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2006
13	Estrogen ReceptorsIBA 01/2022 - 01/2005
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2009
10	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 01/2005
8	MucinsIBA 01/2020 - 05/2008
8	Exonucleases (3' 5' Exonuclease)IBA 01/2020 - 04/2015
8	Biological ProductsIBA 01/2019 - 07/2006
6	ParaffinIBA 01/2021 - 12/2004
6	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2018
6	Hematoxylin (Haematoxylon)IBA 01/2016 - 02/2004
6	Eosine Yellowish-(YS) (Eosin)IBA 01/2016 - 02/2004
5	Estrogens (Estrogen)FDA Link 09/2015 - 09/2004
5	AntibodiesIBA 05/2014 - 09/2003
4	Hormones (Hormone)IBA 01/2022 - 09/2015
4	DesminIBA 01/2021 - 01/2018
4	Cadherins (E-Cadherin)IBA 01/2019 - 10/2002
4	Sucrose (Saccharose)IBA 08/2018 - 03/2016
4	Coloring Agents (Dyes)IBA 01/2017 - 05/2009
4	Keratins (Keratin)IBA 03/2011 - 01/2005
3	MART-1 AntigenIBA 01/2022 - 09/2003
3	Prostaglandin-E SynthasesIBA 01/2020 - 08/2003
3	Cyclin D1IBA 01/2020 - 05/2014
3	Formaldehyde (Formol)FDA Link 01/2020 - 12/2004
3	Mucin-1 (CA 15-3 Antigen)IBA 01/2019 - 01/2005
3	VimentinIBA 01/2019 - 08/2006
3	Hepatocyte Nuclear FactorsIBA 03/2011 - 01/2009
3	AntigensIBA 10/2010 - 01/2005
3	Monoclonal AntibodiesIBA 01/2005 - 10/2002
2	temsirolimus FDA Link 10/2022 - 01/2018
2	Bevacizumab (Avastin)FDA Link 10/2022 - 01/2018
2	Trefoil Factor-2IBA 01/2022 - 01/2021
2	trans-sodium crocetinate (crocetin)IBA 01/2022 - 03/2015
2	taxaneIBA 01/2021 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 10/2008
2	Phenobarbital (Luminal)FDA Link 01/2020 - 01/2018
2	Hepatocyte Nuclear Factor 1-betaIBA 01/2019 - 01/2018
2	Androgen Receptors (Androgen Receptor)IBA 01/2018 - 09/2004
2	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 01/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 01/2009
2	Fumarate Hydratase (Fumarase)IBA 10/2017 - 07/2014
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2017 - 01/2016
2	Tamoxifen FDA LinkGeneric 05/2013 - 05/2006
2	Carcinoembryonic AntigenIBA 05/2011 - 08/2006
2	Messenger RNA (mRNA)IBA 03/2009 - 08/2003
2	beta CateninIBA 10/2008 - 10/2002
2	Inhibins (Inhibin)IBA 07/2008 - 09/2003
1	benzoylalanyl-glycyl-prolineIBA 03/2022
1	Progestins (Progestagens)IBA 03/2022
1	alpha-methylacyl-CoA racemaseIBA 01/2022
1	LigandsIBA 01/2022
1	Cathepsin KIBA 01/2022
1	GenieIBA 01/2021
1	PlatinumIBA 01/2021

Therapy/Procedure

26	Therapeutics 03/2022 - 05/2003
16	Drug Therapy (Chemotherapy) 10/2022 - 01/2009
13	Hysterectomy 01/2021 - 04/2007
9	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 05/2007
4	Radiotherapy 01/2021 - 05/2003
4	Neoadjuvant Therapy 01/2021 - 09/2009
3	Salpingo-oophorectomy 01/2021 - 11/2013
3	Adjuvant Chemotherapy 09/2013 - 03/2009
2	Precision Medicine 02/2018 - 06/2014
2	Immunotherapy 01/2018 - 01/2005
2	Conservative Treatment 07/2016 - 12/2009
1	Length of Stay 01/2020